The #FDA has approved #EliLilly's once-weekly #basalinsulin product #Onswik for adults with #type2diabetes, setting up a market tussle with Novo over its recently launched Awiqli.
@pharmaphorum.bsky.social
Explore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.socialThe #FDA has approved #EliLilly's once-weekly #basalinsulin product #Onswik for adults with #type2diabetes, setting up a market tussle with Novo over its recently launched Awiqli.